Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Natural Capsules Ltd. Share Price
Day's Range
Day's Range
Low
₹160.80
High
₹181.90
Price Summary
| Previous Close | ₹170.18 |
|---|---|
| Day's Range | ₹160.80 - ₹181.90 |
| Open | ₹163.00 |
| 52 Week Range | ₹136.36 - ₹296.00 |
| Volume | 1,03,643 |
| Market Cap | ₹0.00 |
| Previous Close | ₹168.00 |
|---|---|
| Day's Range | ₹161.15 - ₹181.00 |
| Open | ₹168.00 |
| 52 Week Range | ₹137.50 - ₹296.40 |
| Volume | 13,390 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 176.38 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -23.69 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.74 |
| PAT Margin (%) | -13.17 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -4.85 |
| Trade Value ( ₹ in Lacs) | 22.50 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -23.69 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.74 |
| PAT Margin (%) | -13.17 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -4.85 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1692.06 | 449.7 |
| Expenses | N/A | N/A |
| PBT | 27.91 | 8.92 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 6.17 | 5.21 |
About Natural Capsules Ltd.
| Founded | 1993 |
|---|---|
| Managing Director | Sunil L Mundra |
| NSE Symbol | NATCAPSUQ |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,67,630.39 | 1,952.75 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,18,971.76 | 8,275.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,88,358.16 | 4,915.50 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,29,125.81 | 8,921.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,915.99 | 1,460.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,11,241.63 | 1,120.70 | 835.50 - 835.50 |
| Lupin Ltd. | 1,07,907.43 | 2,275.00 | 1,875.00 - 1,875.00 |
| Max Healthcare Institute Ltd. | 1,04,432.24 | 1,070.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,00,729.72 | 2,438.00 | 1,909.70 - 1,909.70 |
| Laurus Labs Ltd. | 1,00,227.92 | 1,866.00 | 810.05 - 810.05 |
No Records Found
Latest News
Natural Capsules informs about AGM
Natural Capsules informs about compliances-certificate
Glenmark Pharmaceuticals informs about allotment of shares under ESOP
Glenmark Pharmaceuticals has informed that the Company has allotted 23,863 Equity Shares of Re 1 each on August 10, 2026, to the grantee who had exercised the options under the Company's Employee Stock Option Plan 2016 (ESOP 2016). With this allotment, the paid-up capital of the Company has increased from Rs 28,22,00,809 divided into 28,22,00,809 number of equity shares of face value Re 1 each to Rs. 28,22,24,672 divided into 28,22,24,672 number of equity shares of face value Re 1 each. The details as required under the SEBI (Share Based Employee Benefits and Sweat equity) Regulations, 2021 are enclosed as Annexure - I.
The above information is a part of company’s filings submitted to BSE.
Akums Drugs and Pharmaceuticals informs about newspaper advertisements
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals has informed that it enclosed copies of the newspaper advertisements published on August 09, 2026 in the newspapers: Financial Express (English -New Delhi Edition) and Jansatta (Hindi - New Delhi Edition). The advertisements contain a Quick Response (QR) Code enabling direct access to the unaudited (Standalone & Consolidated) Financial Results of the company for the quarter ended June 30, 2026 as approved by the Board of Directors at its meeting held on August 08, 2026. A copy of this disclosure is being updated on the website of the Company at www.akums.in.
The above information is a part of company’s filings submitted to BSE.
Corona Remedies informs about analyst meet
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Natural Capsules Ltd. is ₹170.18 as of 2026-08-10.
The market capitalisation of Natural Capsules Ltd. is ₹162.21 as of 2026-08-07.
The 1-year return of Natural Capsules Ltd. is -41.45% as of 2026-08-10.
The P/E ratio of Natural Capsules Ltd. is 0.00 as of 2026-08-10.
The 52-week high and low of Natural Capsules Ltd. are ₹296.00 and ₹136.36, respectively, as of 2026-08-10.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
